Kezar Life Sciences Inc (NAS:KZR) Stock News, Headlines & Updates
Kezar Life Sciences Inc Stock News from GuruFocus
- 1
Jul 16, 2025
KZR: Kezar Life Sciences Maintains Neutral Rating by HC Wainwright & Co. | KZR Stock News
GuruFocus News • 7:01am
Jul 15, 2025
Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis | KZR Stock News
GuruFocus News • 4:01pm
Kezar Life Sciences (KZR) Seeks to Lift Hold on Zetomipzomib Trials | KZR Stock News
GuruFocus News • 4:00pm
Kezar Life Sciences Announces FDA Has Lifted Partial Clinical Hold on PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis
Business Wire • 4:00pm
May 28, 2025
Kezar Life Sciences to Participate in the Jefferies Global Healthcare Conference
Business Wire • 4:00pm
May 13, 2025
Kezar Life Sciences Reports First Quarter 2025 Financial Results and Provides Business Update
Business Wire • 4:00pm
KZR Reports Financial Status and Progress in AIH Treatment Trials | KZR Stock News
GuruFocus News • 3:38pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news